As Citrix Sys (CTXS) Share Price Declined, Shareholder Credit Agricole S A Has Trimmed Stake by $340,770; Wcm Investment Management Holding in Core Laboratories N V (CLB) Cut by $47.74 Million as Stock Declined

Core Laboratories N.V. (NYSE:CLB) Logo

Wcm Investment Management decreased its stake in Core Laboratories N V (CLB) by 7.85% based on its latest 2018Q3 regulatory filing with the SEC. Wcm Investment Management sold 415,096 shares as the company’s stock declined 31.55% with the market. The institutional investor held 4.87 million shares of the oilfield services and equipment company at the end of 2018Q3, valued at $564.10M, down from 5.29M at the end of the previous reported quarter. Wcm Investment Management who had been investing in Core Laboratories N V for a number of months, seems to be less bullish one the $2.92B market cap company. The stock increased 0.95% or $0.62 during the last trading session, reaching $65.98. About 610,417 shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 26.38% since February 13, 2018 and is downtrending. It has underperformed by 26.38% the S&P500. Some Historical CLB News: 25/04/2018 – CORE LABORATORIES NV CLB.N – QTRLY OPERATING MARGINS OF 19%, UP 400 BPS YEAR-OVER-YEAR; 25/04/2018 – CORE LABORATORIES 1Q ADJ EPS 57C, EST. 57C; 25/04/2018 – CORE LAB SEES 2Q REV. ABOUT $177M-$179M, EST. $178.0M; 27/04/2018 – CORE LABORATORIES NV CLB.N : DEUTSCHE BANK RAISES TARGET PRICE TO $120 FROM $109; 25/04/2018 – CORE LABORATORIES SEES 2Q EPS 64C TO 66C, EST. 66C; 25/04/2018 – CORE LABORATORIES NV CLB.N – QTRLY SHR $0.57 EXCLUDING ITEMS

Credit Agricole S A decreased its stake in Citrix Sys Inc (CTXS) by 7.97% based on its latest 2018Q3 regulatory filing with the SEC. Credit Agricole S A sold 3,070 shares as the company’s stock declined 2.02% with the market. The institutional investor held 35,427 shares of the technology company at the end of 2018Q3, valued at $3.94M, down from 38,497 at the end of the previous reported quarter. Credit Agricole S A who had been investing in Citrix Sys Inc for a number of months, seems to be less bullish one the $14.15B market cap company. The stock decreased 0.41% or $0.43 during the last trading session, reaching $105.01. About 1.02M shares traded. Citrix Systems, Inc. (NASDAQ:CTXS) has risen 24.53% since February 13, 2018 and is uptrending. It has outperformed by 24.53% the S&P500. Some Historical CTXS News: 25/04/2018 – CITRIX 1Q NET REV. $697.2M, EST. $675.6M; 25/04/2018 – Citrix Systems 1Q Net $144.3M; 17/04/2018 – Citrix Analytics Service Proactively Addresses Security Threats; 26/04/2018 – CAFC: 01 COMMUNIQUE LABORATORY, INC v. CITRIX ONLINE, LLC [OPINION] – Appeal #17-1869 – 2018-04-26; 05/04/2018 – Instart Logic Names Former Citrix CEO Mark Templeton as Chairman; 06/03/2018 – TechTarget’s SearchVirtualDesktop.com Announces Call for Nominations for Best of Citrix Synergy 2018 Awards; 09/04/2018 – LogMeIn Names Sara Andrews to Board of Directors; 25/04/2018 – Citrix Raises Annual Forecast Following Strong 1Q Results — Market Mover; 26/04/2018 – CITRIX SYSTEMS INC CTXS.O : BERENBERG RAISES TARGET PRICE TO $107 FROM $105; 25/04/2018 – Citrix Systems Sees FY Rev $2.88B-$2.91B

Credit Agricole S A, which manages about $2.09B US Long portfolio, upped its stake in Ameriprise Finl Inc (NYSE:AMP) by 22,282 shares to 87,224 shares, valued at $12.88M in 2018Q3, according to the filing. It also increased its holding in Avery Dennison Corp (NYSE:AVY) by 9,752 shares in the quarter, for a total of 20,752 shares, and has risen its stake in Bristol Myers Squibb Co (NYSE:BMY).

Among 26 analysts covering Citrix Systems Inc. (NASDAQ:CTXS), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Citrix Systems Inc. had 99 analyst reports since July 29, 2015 according to SRatingsIntel. Needham maintained the shares of CTXS in report on Thursday, October 22 with “Buy” rating. RBC Capital Markets maintained the stock with “Sector Perform” rating in Thursday, October 22 report. Barclays Capital downgraded the shares of CTXS in report on Monday, January 8 to “Equal-Weight” rating. The stock of Citrix Systems, Inc. (NASDAQ:CTXS) has “Sell” rating given on Friday, July 7 by Jefferies. The firm has “Buy” rating by M Partners given on Thursday, April 21. The rating was maintained by Cowen & Co on Thursday, October 20 with “Outperform”. The firm has “Overweight” rating by Barclays Capital given on Thursday, August 3. The rating was maintained by RBC Capital Markets on Sunday, September 3 with “Hold”. Morgan Stanley maintained it with “Underweight” rating and $84 target in Thursday, October 20 report. The firm earned “Buy” rating on Monday, December 5 by Mizuho.

More notable recent Citrix Systems, Inc. (NASDAQ:CTXS) news were published by: Nasdaq.com which released: “Technology Sector Update for 01/24/2019: LRCX,XLNX,CTXS – Nasdaq” on January 24, 2019, also Nasdaq.com with their article: “Daily Dividend Report: NSC, LVS, XLNX, BLL, CTXS – Nasdaq” published on January 24, 2019, Businesswire.com published: “Saab Teams with Citrix and DXC Technology to Create Intelligent Digital Workspace, Fuel Collaboration and Innovation Across Global Operations – Business Wire” on January 15, 2019. More interesting news about Citrix Systems, Inc. (NASDAQ:CTXS) were released by: Investorplace.com and their article: “3 Big Stock Charts for Tuesday: Micron Technology, Citrix Systems and Vulcan Materials – Investorplace.com” published on February 12, 2019 as well as Nasdaq.com‘s news article titled: “Noteworthy Thursday Option Activity: ALK, KR, CTXS – Nasdaq” with publication date: January 24, 2019.

Since August 29, 2018, it had 0 buys, and 15 selling transactions for $6.21 million activity. 1,466 shares valued at $162,393 were sold by SOISSON JESSICA on Thursday, December 13. The insider Minahan Timothy A. sold $644,389. $875,106 worth of Citrix Systems, Inc. (NASDAQ:CTXS) was sold by HOUGH PAUL J.. 7,766 shares valued at $852,551 were sold by VAN ROTTERDAM JEROEN on Thursday, October 4. 1,388 shares were sold by FERRER MARK J, worth $141,507.

Investors sentiment increased to 1.26 in Q3 2018. Its up 0.14, from 1.12 in 2018Q2. It improved, as 25 investors sold CTXS shares while 163 reduced holdings. 76 funds opened positions while 160 raised stakes. 118.38 million shares or 2.96% less from 121.98 million shares in 2018Q2 were reported. Omers Administration invested 0.08% in Citrix Systems, Inc. (NASDAQ:CTXS). Eaton Vance Mgmt holds 0.01% of its portfolio in Citrix Systems, Inc. (NASDAQ:CTXS) for 39,709 shares. 309,160 are owned by Mackay Shields Limited Com. Ascend Cap Lc accumulated 98,599 shares. London Of Virginia, Virginia-based fund reported 410,453 shares. 72 are owned by Farmers Merchants Incorporated. Adage Cap Prns Grp Incorporated Ltd Liability reported 164,300 shares or 0.04% of all its holdings. Tci Wealth Advsrs holds 0% or 10 shares in its portfolio. Johnson Counsel has 2,114 shares. American Intll Grp Incorporated Incorporated has 0.02% invested in Citrix Systems, Inc. (NASDAQ:CTXS). 955,660 are held by Voya Invest Mgmt. Cambridge Trust Com owns 0.1% invested in Citrix Systems, Inc. (NASDAQ:CTXS) for 15,107 shares. Pinebridge Invests LP reported 6,914 shares. Natixis Advsrs Limited Partnership reported 100,027 shares. Boston Prns stated it has 0% in Citrix Systems, Inc. (NASDAQ:CTXS).

More notable recent Core Laboratories N.V. (NYSE:CLB) news were published by: Seekingalpha.com which released: “Core Labs: The Valuation Remains Untenable – Seeking Alpha” on November 25, 2018, also Zacks.com with their article: “Core Laboratories (CLB) Q4 Earnings and Revenues Lag Estimates – Zacks.com” published on January 30, 2019, Seekingalpha.com published: “Core Laboratories Q4 2018 Earnings Preview – Seeking Alpha” on January 29, 2019. More interesting news about Core Laboratories N.V. (NYSE:CLB) were released by: Zacks.com and their article: “Core Laboratories (CLB) Q4 Earnings: Disappointment in Store? – Zacks.com” published on January 25, 2019 as well as Streetinsider.com‘s news article titled: “Form 8-K CORE LABORATORIES NV For: Jan 15 – StreetInsider.com” with publication date: January 15, 2019.

Wcm Investment Management, which manages about $11.16 billion US Long portfolio, upped its stake in Amphenol Corp New (NYSE:APH) by 72,171 shares to 1.31 million shares, valued at $123.04 million in 2018Q3, according to the filing. It also increased its holding in Thermon Group Hldgs Inc (NYSE:THR) by 13,740 shares in the quarter, for a total of 285,531 shares, and has risen its stake in West Pharmaceutical Svsc Inc (NYSE:WST).

Investors sentiment decreased to 1.05 in 2018 Q3. Its down 0.05, from 1.1 in 2018Q2. It turned negative, as 34 investors sold CLB shares while 100 reduced holdings. 41 funds opened positions while 100 raised stakes. 47.88 million shares or 0.90% less from 48.31 million shares in 2018Q2 were reported. Qs Invsts Lc owns 26 shares. Parsons Cap Mngmt Incorporated Ri holds 3,360 shares. Riverpark Limited invested 1.64% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Oppenheimer Asset Mngmt has 39,810 shares. Ftb Advsr has invested 0% in Core Laboratories N.V. (NYSE:CLB). Tower Research Capital Lc (Trc) holds 5,213 shares. Michigan-based State Treasurer State Of Michigan has invested 0.01% in Core Laboratories N.V. (NYSE:CLB). Wedgewood Prns Incorporated has 426,000 shares. Corecommodity Management Ltd Limited Liability Company owns 7,354 shares for 0.43% of their portfolio. 8,160 are owned by Brinker Capital Inc. Alabama-based Regions has invested 0.02% in Core Laboratories N.V. (NYSE:CLB). Kistler reported 16 shares. Moreover, Arrowmark Colorado Ltd Company has 0.05% invested in Core Laboratories N.V. (NYSE:CLB) for 50,000 shares. Ashford Capital Management has invested 0.5% in Core Laboratories N.V. (NYSE:CLB). Torray Ltd Liability Co has invested 0.09% in Core Laboratories N.V. (NYSE:CLB).

Among 25 analysts covering Core Laboratories (NYSE:CLB), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Core Laboratories had 71 analyst reports since August 24, 2015 according to SRatingsIntel. On Friday, September 1 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Core Laboratories N.V. (NYSE:CLB) earned “Buy” rating by Guggenheim on Friday, November 16. On Thursday, July 20 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock has “Sector Perform” rating by Howard Weil on Friday, January 29. As per Wednesday, October 25, the company rating was maintained by UBS. Cowen & Co maintained the shares of CLB in report on Friday, April 13 with “Hold” rating. As per Monday, April 24, the company rating was maintained by ABN Amro. The firm earned “Hold” rating on Monday, October 23 by Piper Jaffray. UBS maintained the shares of CLB in report on Wednesday, July 26 with “Neutral” rating. The firm has “Neutral” rating given on Friday, September 14 by Citigroup.

Citrix Systems, Inc. (NASDAQ:CTXS) Institutional Positions Chart